Is clopidogrel better than prasugrel?
We found two trials that showed prasugrel (TRITON-TIMI 38 trial) and ticagrelor (PLATO trial) are superior to clopidogrel at reducing cardiovascular death and reducing myocardial infarction and stroke.
Is prasugrel more potent than clopidogrel?
Prasugrel is a new thienopyridine that is more potent than standard-dose clopidogrel in healthy subjects and patients with stable coronary artery disease.
When do you use prasugrel over clopidogrel?
The 2016 American College of Cardiology/American Heart Association Dual Antiplatelet Therapy update recommends prasugrel over clopidogrel (class IIa recommendations) in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI) except for those who are at high risk for bleeding (such as …
Does clopidogrel cause low blood sugar?
We postulate that the activated form of clopidogrel may bind with disulfide bond of the insulin molecule, making the latter more immunogenic, and cause hypoglycemia as described previously.
Can I take clopidogrel and metformin together?
Interactions between your drugs No interactions were found between metformin and Plavix. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
What is the best alternative to clopidogrel?
Besides oral anticoagulants, such as warfarin and the more recent dabigatran[9], and niche agents, such as cilostazol and ticlopidine[10,11], the most promising alternatives to clopidogrel in those with background aspirin therapy are prasugrel and ticagrelor.
How do I switch from clopidogrel to prasugrel?
FROM CLOPIDOGREL to PRASUGREL In the presence of high risk of coronary thrombosis, give a 60 mg loading dose of prasugrel, followed by the maintenance dose of 10 mg daily (irrespective of timing of the last dose of clopidogrel).
Does clopidogrel affect blood sugar?
These results could indicate that clopidogrel has glucose lowering effect and the FSG level in placebo treated group significantly elevated after the same course of treatment.
What should you not take with clopidogrel?
Some medicines affect the way clopidogrel works. Tell your doctor if you’re taking any of these medicines before you start taking clopidogrel: medicines to prevent blood clots, such as aspirin, warfarin, rivaroxaban, apixaban, edoxaban, dabigatran, dipyridamole, ticagrelor or prasugrel.
Can clopidogrel damage kidneys?
Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome.
When should you not use prasugrel?
Warnings
- Do not use in patients with active bleeding or a history of transient ischemic attack (TIA) or stroke.
- Generally not recommended for age over 75 years (increased risk of fatal and intracranial bleeding and uncertain benefit, except in high-risk patients [diabetes or prior heart attack/myocardial infarction])
How long can you stay on prasugrel?
The optimal duration of dual antiplatelet therapy with prasugrel after TAXUS Liberté paclitaxel-eluting stent remains unknown, but appears to be >30 months.
Do you load prasugrel?
The use of an initial loading dose of prasugrel 60 mg was recommended in all patients irrespective of pre-treatment with clopidogrel, followed by a daily dose of 10 mg. Prasugrel, in addition to a loading dose of clopidogrel, was administered in the cath lab just before, during, or immediately after primary PCI.
Which is better clopidogrel or prasugrel?
In diabetics, prasugrel was associated with a lower adjusted risk of 90-day death compared with clopidogrel. Use of prasugrel in diabetic patients with PCI-treated ACS was lower than in non-diabetics despite their high-risk profile and the severity of their clinical presentation.
What are the possible complications of prasugrel and clopidogrel?
Major bleeding was observed in 2.4% of patients receiving prasugrel and in 1.8% of patients receiving clopidogrel (hazard ratio, 1.32; 95% CI, 1.03 to 1.68; P=0.03).
Does prasugrel reduce the risk of stent thrombosis?
The rate of definite or probable stent thrombosis, as defined by the Academic Research Consortium, was significantly reduced in the prasugrel group as compared with the clopidogrel group, with 68 patients (1.1%) and 142 patients (2.4%), respectively, having at least one occurrence (hazard ratio, 0.48; 95% CI, 0.36 to 0.64; P<0.001).
What is the efficacy of prasugrel and clopidogrel in the treatment of Timi hemorrhage?
Among patients treated with prasugrel, 146 (2.4%) had at least one TIMI major hemorrhage that was not related to CABG, as compared with 111 patients (1.8%) treated with clopidogrel (hazard ratio, 1.32; 95% CI, 1.03 to 1.68; P=0.03) ( Table 3 ).